Exagen (XGN) Consolidated Net Income (2018 - 2026)

Exagen (XGN) has 9 years of Consolidated Net Income data on file, last reported at -$4.0 million in Q1 2026.

• Quarterly Consolidated Net Income fell 5.73% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 30.04% YoY) and the FY2025 annual result came in at -$20.0 million, down 31.99% from the prior year.
• Consolidated Net Income rose to -$4.0 million in Q1 2026, from -$4.7 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of -$3.0 million in Q2 2024 to a low of -$17.3 million in Q1 2022.
• A 5-year average of -$7.1 million and a median of -$5.0 million in 2024 frame the typical range for Consolidated Net Income.
• Annual changes were most pronounced in 2022 — Consolidated Net Income slumped 179.03% — and 2023, when it soared 69.94%.
• Tracing XGN's Consolidated Net Income over 5 years: stood at -$14.4 million in 2022, then jumped by 62.68% to -$5.4 million in 2023, then jumped by 30.03% to -$3.8 million in 2024, then retreated by 24.25% to -$4.7 million in 2025, then climbed by 15.11% to -$4.0 million in 2026.
• The last three Consolidated Net Income figures came in at -$4.0 million (Q1 2026), -$4.7 million (Q4 2025), and -$7.1 million (Q3 2025), per Business Quant data.